News from takeda pharmaceuticals u.s.a., inc

May 22, 2014, 16:52 ET

Jury Finds for Takeda in Diabetes Drug Case

Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Bertha Triana and Delores Cipriano v. Takeda, et al., No. A680556 the...

May 15, 2014, 16:52 ET

Jury Finds for Takeda in Diabetes Drug Case

 Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Whitlatch v. Takeda the jury found in favor of Takeda. The trial...

Apr 08, 2014, 00:51 ET

Takeda Responds to Verdict in Diabetes Drug Case

 Takeda Pharmaceuticals U.S.A., Inc. announced that in the case of Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al,...

Jan 21, 2014, 09:00 ET

Takeda and Lundbeck Announce Brintellix® (vortioxetine) for the Treatment of Major Depressive Disorder in Adults is Now Available in Pharmacies

Takeda Pharmaceuticals U.S.A., Inc. (Takeda) and Lundbeck US jointly announced today that Brintellix (vortioxetine), for the treatment of major...

Nov 14, 2013, 10:43 ET

Takeda's Deerfield Campus Among Chicago Tribune's 2013 Top 100 Workplaces

Takeda Pharmaceuticals announced today that the Chicago Tribune named Takeda's Deerfield campus among Chicago's Top 100 Workplaces in...

Nov 11, 2013, 16:30 ET

Orexigen and Takeda Announce Multiple Contrave Data Presentations at the ObesityWeek Meeting in Atlanta

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) and Takeda Pharmaceuticals U.S.A., Inc. (Takeda), today announced multiple Contrave®...

Sep 26, 2013, 18:57 ET

Takeda Responds to Verdict in Diabetes Drug Case

 Takeda Pharmaceuticals U.S.A., Inc. today announced that in the case of An, et al. v. Takeda, judgment was entered in favor of the company....

Jul 09, 2013, 08:00 ET

Pro Athletes Team Up to Champion Gout Awareness

For Emmitt Smith, Pro Football running back legend, as an athlete, pain was a part of the job. Yet he describes a gout flare as a level of pain...

Jul 02, 2013, 09:00 ET

Takeda Ranked Among Chicago's Best and Brightest Companies

 The National Association for Business Resources (NABR) has listed Takeda among Chicago's 101 Best and Brightest Companies to Work For™....

May 01, 2013, 17:03 ET

Judge Nullifies Verdict in Diabetes Drug Case

Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Jack Cooper, et al. v. Takeda Pharmaceuticals America, Inc., et al., No....

Apr 26, 2013, 19:38 ET

Takeda Responds to Verdict in Diabetes Drug Case

 Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Jack Cooper et al. v. Takeda Pharmaceuticals America, Inc., et al.,...

Nov 13, 2012, 10:15 ET

Takeda's Deerfield Campus Ranked Among Chicago's Top 100 Workplaces in 2012

 Takeda Pharmaceuticals U.S.A., Inc. and Takeda Global Research & Development Center, Inc. today announced the Chicago Tribune has...

Sep 05, 2012, 08:00 ET

American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide

Results of a 10-week, phase 3 study published online in the American Journal of Medicine found the clinic systolic blood pressure (SBP)...

Jun 19, 2012, 08:00 ET

Edarbyclor (azilsartan medoxomil and chlorthalidone) Head-to-Head Data Published in Hypertension

Results of a 12-week, head-to-head, phase 3 study published online in the American Heart Association journal Hypertension found systolic...

May 02, 2012, 06:00 ET

Chef Spike Mendelsohn Dishes on How to Turn Down the Heat on Acid Reflux Disease

 Celebrity chef Spike Mendelsohn knows all too well the effects of a busy and hectic lifestyle – especially for a person with acid reflux...

Mar 05, 2012, 08:00 ET

Memphis Included in Analysis of Top Hypertension Hot Spots in the United States

A national analysis conducted by Sperling's BestPlaces and sponsored by Takeda Pharmaceuticals U.S.A., Inc., identified Memphis, Tenn., as...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge